Chargement en cours...
Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review
Since December 2019, the COVID-19 pandemic has become a major public health problem. To date, there is no evidence of a higher incidence of COVID in patients with autoimmune rheumatic diseases and we support the approach of maintaining chronic rheumatological treatments. However, once infected there...
Enregistré dans:
| Publié dans: | Therapie |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7320663/ https://ncbi.nlm.nih.gov/pubmed/32665090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.therap.2020.06.013 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|